Filter
857
Text search:
pharmaceutical
regulations
Featured
70
238
Language
Document type
425
168
141
46
45
11
10
6
3
1
1
Countries / Regions
48
28
26
26
24
23
22
21
19
18
18
18
17
17
13
13
12
11
11
10
10
9
9
9
8
7
7
7
6
6
6
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
388
35
29
26
23
13
6
Toolboxes
137
91
73
35
35
30
29
18
17
14
12
11
10
8
8
6
5
2
2
2
1
1
1
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
PMPB/INS-GUIDE/01
Doc. No.: INS/GDL/001-(Annexes)
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An imperfect rollout
TB in South African prisons: Where to now?
Decentralising DR-TB care: How far alon
...
